1. An integrative transcriptomic analysis reveals bisphenol A exposure-induced dysregulation of microRNA expression in human endometrial cells
   Wei-Chun Chou et al, 2017, Toxicology in Vitro CrossRef
2. p21-activated kinases as viable therapeutic targets for the treatment of high-risk Ewing sarcoma
   Shawki L. Qasim et al, 2021, Oncogene CrossRef
3. Spatio‐temporal localization of P21‐activated kinase in endometrial cancer
   Joydeep Roy et al, 2024, Biotechnology and Applied Biochemistry CrossRef
4. Expression of P21‐activated kinase 1 and cell division control protein 42 homolog correlates with clinicopathological features and prognosis in cervical carcinoma
   Yimin Feng et al, 2016, Journal of Obstetrics and Gynaecology Research CrossRef
5. PAKs in Human Cancer Progression
   R. Kumar et al, 2016, CrossRef
6. Clinicopathological and cellular signature of PAK1 in human bladder cancer
   Kai Huang et al, 2015, Tumor Biology CrossRef
7. Role of p-21-Activated Kinases in Cancer Progression
   Helen King et al, 2014, CrossRef
8. Potential Compensation among Group I PAK Members in Hindlimb Ischemia and Wound Healing
   Laila Elsherif et al, 2014, PLoS ONE CrossRef
9. Gene expression profiling of lung adenocarcinoma in Xuanwei, China
   Huifei Wu et al, 2016, European Journal of Cancer Prevention CrossRef
10. Bioinformatic mining of kinase inhibitors that regulate autophagy through kinase signaling pathways
    YANG YANG et al, 2014, Molecular Medicine Reports CrossRef